An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease. in Respirology (Carlton, Vic.) / Respirology. 2020 Nov;25 Suppl 2:24-36. doi: 10.1111/resp.13965. Epub 2020 Oct 29.

2020
AOU San Luigi di Orbassano

Tipo pubblicazione

Review

Autori/Collaboratori (5)Vedi tutti...

Novello S
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy.
Reale ML
Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy.
Rigney M
GO2 Foundation for Lung Cancer, Washington, DC, USA.

et alii...

Abstract

Lung cancer remains the leading cause of cancer death globally, yet with many recent advances in the diagnosis and treatment of lung cancer, the face of the disease is shifting. Historically, lung cancer is often thought of as a predominantly male disease with more than twice as many men as women being diagnosed worldwide-mostly due to the influence of smoking as the leading risk factor. However, lung cancer is also the second leading cause of cancer death in women and there is a growing population of young women who have never smoked and are being diagnosed. The past decade has seen groundbreaking innovations in both the early detection and treatment of lung cancer. In this new era, survival rates are beginning to increase and many of those diagnosed are finding themselves in a new situation-living long term with a deadly cancer. Here, we review pertinent aspects of women and lung cancer as well as the concept of living with lung cancer as a chronic disease to give a new perspective on the changing face of lung cancer treatment and care.

Accesso banca dati bibliografica

Accedi alla scheda bibliografica del documento in PUBMED

Se sei accreditato in BVS-P effettua prima l'accesso per utilizzare i nostri servizi.

PMID : 33124087

DOI : 10.1111/resp.13965

Keywords

Hormones; Female; Chronic Disease; Cancer Survivors; Smoking/epidemiology; Risk Factors; Lung Neoplasms/diagnostic imaging/epidemiology/prevention & control/therapy; Immunotherapy; Humans; survivorship; lung cancer; gender differences; chronic disease; Tobacco Smoke Pollution;